A new method to evaluate spontaneous platelet aggregation in type 2 diabetes by Cellfacts

Clinica Chimica Acta

Volumn 329, Issue 1-2, 2003, Pages 95-102

  Gabbianelli, Rosita ^a   Falcioni, Giancarlo ^a   Dow, Crawford S ^b   Vince, Frank P ^c   Swoboda, Ben ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Hospital of Coventry and Warwickshire   (United Kingdom)

Author keywords

Cellfacts; Platelet derived microparticles; Spontaneous platelet aggregation; Type 2 diabetes mellitus; Vitamin E; WEB 2086 BS

Indexed keywords

ALPHA TOCOPHEROL; APAFANT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ADULT; AGED; ANALYZER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IMPEDANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

EID: 0037362616     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00012-3     Document Type: Article

References (23)

1. Spanghenberg P., Schymik C., Hofmann B., Ostermann G., Fuhling K., Till U. Blood platelet behaviour in patients with a type I diabetes mellitus. Exp. Clin. Endocrinol. 94(3):1989;329-337.
2. Cho N.H., Becker D.J., Ellis D., Kuller L.H., Drash A.L., Orchard T.J. Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study. J. Diabetes Complications. 6(1):1992;12-18.
3. Paulsen E.P., McClung N.M., Sabio H. Some characteristics of spontaneous platelet aggregation in young insulin-dependent diabetic subjects. Horm. Metab. Res., Suppl. 11:1981;15-21.
4. Michelson A.D. Flow cytometry: a clinical test of platelet function. Blood. 87(12):1996;4925-4937.
5. Winocour P.D. Platelet abnormalities in diabetes mellitus. Diabetes. 41(Suppl. 2):1992;26-31.
6. Kore R.N., Dow C.S., Desai K.M. A new automated system for urine analysis: a simple, cost-effective and reliable method for distinguishing between glomerular and nonglomerular sources of haematuria. BJU Int. 84(4):1999;454-460.
7. Gentelet H., Carricajo A., Rusch P., Dow C., Auber G. Evaluation of a new rapid urine screening analyser: cellfacts. Pathol. Biol. 49:2001;262-264.
8. Negro Alvarez J.M., Miralles Lopez J.C., Ortiz Martinez J.L., Abellan Aleman A., Rubio del Bario R. Platelet-activating factor antagonists. Allergol. Immunopathol. 25(5):1997;249-258.
9. Nguyen P., Petitfrere E., Potron G. Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists. Thromb. Res. 1(78):1995;33-42.
10. Lagente V., Boichot E., Carre C., Guinot P., Mencia-Huerta J.M., Braque P. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs. Clin. Exp. Allergy. 23(12):1993;1002-1010.
11. Szuwart T., Brzoska T., Luger T.A., Filler T., Peuker E., Dierichs R. Vitamin E reduces platelet adhesion to human endothelial cells in vitro. Am. J. Hematol. 65(1):2000;1-4.
12. Siljander P., Carpen O., Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood. 87:1996;4651-4663.
13. George J.N., Thoi L.L., McManus L.M., Reimann T.A. Isolation of human platelet membrane microparticles from plasma and serum. Blood. 60:1982;834-840.
14. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H.et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 88:1996;3456-3464.
15. Geiser T., Sturzennegger M., Genewein U., Haeberli A., Beer J.H. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves. Stroke. 29:1998;1770-1777.
16. Singh N., Gemell C.H., Dalay P.A., Yeo E.L., Can J. Elevated platelet-derived microparticle levels during unstable angina. Cardiology. 11:1995;1015-1021.
17. Gawaz M., Neumann F.J., Ott I., Schiessler A., Schoming A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 93:1996;229-237.
18. Nomura S., Suzuki M., Katsura K., Xie G., Miyazaki Y., Miyake T.et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 116:1995;235-240.
19. Montrucchio G., Alloatti G., Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev. 80(4):2000;1666-1669.
20. De La Cruz J.P., Moreno A., Ruiz-Ruiz M.I., Garcia-Campos J., Sanchez de la Cuesta F. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats. Eur. J. Pharmacol. 360(1):1998;37-42.
21. Suzuki M., Sugatani J., Ino M., Shimura M., Akiyama M., Yamazaki R.et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Am. J. Physiol. 274(1 Pt. 1):1998;C47-C57.
22. Iwase E., Tawata M., Aida K., Ozaki Y., Kume S., Satoh K.et al. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism. 47(6):1998;699-705.
23. Hendra T.J., Yudkin J.S. 'Spontaneous' platelet aggregation in whole blood in diabetic patients with and without microvascular disease. Diabet. Med. 9(3):1992;247-251.